Genetics and implications in perioperative analgesia
AM Trescot - Best Practice & Research Clinical Anaesthesiology, 2014 - Elsevier
The wide range of patient responses to surgical pain, opioids, and anesthetic agents has
puzzled anesthesiologists for many years. Much of the variation has been attributed to …
puzzled anesthesiologists for many years. Much of the variation has been attributed to …
Influence of clinical and genetic factors on propofol dose requirements: A genome-wide association study
S Ahlström, P Bergman, R Jokela, KT Olkkola… - …, 2024 - pubs.asahq.org
Background Propofol is a widely used intravenous hypnotic. Dosing is mostly based on
weight with great interindividual variation in consumption. Suggested factors affecting …
weight with great interindividual variation in consumption. Suggested factors affecting …
[HTML][HTML] Impact of gender on efficacy and acute toxicity of alkylating agent-based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial
H van den Berg, M Paulussen, G Le Teuff… - European journal of …, 2015 - Elsevier
Background Based on the randomised Euro-EWING99-R1 trial, vincristine, adriamycin,
cyclophosphamide (VAC) may be able to replace vincristine, adriamycin, ifosfamide (VAI) in …
cyclophosphamide (VAC) may be able to replace vincristine, adriamycin, ifosfamide (VAI) in …
Clinical pharmacology of frequently used intravenous drugs during bariatric surgery in adolescents
JD Vaughns, VC Ziesenitz… - Current …, 2015 - ingentaconnect.com
Obesity represents one of the most important public health issues according to the World
Health Organization. Additionally, in a recent National Health and Nutrition Survey of 2011 …
Health Organization. Additionally, in a recent National Health and Nutrition Survey of 2011 …
[HTML][HTML] Mechanisms and implications in gene polymorphism mediated diverse reponses to sedatives, analgesics and muscle relaxants
Y Sun, H Zhu, E Esmaeili, X Tang… - Korean Journal of …, 2023 - synapse.koreamed.org
Responses to sedatives, analgesics and muscle relaxants vary among patients under
general anesthesia, which could be ascribed to the disparities of clinical characteristics and …
general anesthesia, which could be ascribed to the disparities of clinical characteristics and …
[HTML][HTML] Sex, drugs, and anaesthesia research
In this issue of the British Journal of Anaesthesia, Joksimovic and colleagues report
significant sex differences in sensitivity to the behavioural and neurophysiological effects of …
significant sex differences in sensitivity to the behavioural and neurophysiological effects of …
[HTML][HTML] CYP2B6 genotype guided dosing of propofol anesthesia in the elderly based on nonparametric population pharmacokinetic modeling and simulations
AR Eugene - International journal of clinical pharmacology & …, 2017 - ncbi.nlm.nih.gov
Objective The primary aim of this article is to test the hypothesis that nonparametric
pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on …
pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on …
Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics
A Kanaya, T Sato, N Fuse, H Yamaguchi, N Mano… - Journal of …, 2018 - Springer
Purpose Propofol is one of the most widely used fast-acting intravenously administered
anesthetics. However, although large inter-individual differences in dose requirements and …
anesthetics. However, although large inter-individual differences in dose requirements and …
Procedural sedation for MRI in children with ADHD
E Kitt, J Friderici, R Kleppel, M Canarie - Pediatric Anesthesia, 2015 - Wiley Online Library
Background Attention‐deficit hyperactivity disorder (ADHD) is the most common
neurobehavioral disorder of childhood, affecting 5–8% of children. It has been observed that …
neurobehavioral disorder of childhood, affecting 5–8% of children. It has been observed that …
[HTML][HTML] 17β-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expression via estrogen receptor α
Abstract UDP-glucuronosyltransferase 1A9 (UGT1A9) is a major phase II enzyme
responsible for elimination of drugs and endogenous molecules. Clinical data have shown …
responsible for elimination of drugs and endogenous molecules. Clinical data have shown …